CARIS LIFE SCIENCES, INC. Comprehensive Income
CARIS LIFE SCIENCES, INC. (CAI) reported Comprehensive Income of -$1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$1.00M.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$553.00K.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $82.14M.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $24.40M.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$67.36M.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$281.90M.
- CARIS LIFE SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$342.89M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00M 10-Q · filed 2026-08-05 | -$1.55M 10-Q · filed 2026-08-05 | $80.59M derived: sum of 3 quarters · filed 2026-08-05 | $105.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$553.00K 10-Q · filed 2026-05-08 | $81.59M derived: sum of 2 quarters · filed 2026-05-08 | $106.00M derived: sum of 3 quarters · filed 2026-05-08 | $34.63M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $82.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $106.55M derived: sum of 2 quarters · filed 2026-03-03 | $35.18M derived: sum of 3 quarters · filed 2026-08-05 | -$67.36M 10-K · filed 2026-03-03 |
| 2025-09-30 | $24.40M 10-Q · filed 2025-11-05 | -$46.96M derived: sum of 2 quarters · filed 2026-08-05 | -$149.51M 10-Q · filed 2025-11-05 | -$186.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$71.37M 10-Q · filed 2026-08-05 | -$173.91M 10-Q · filed 2026-08-05 | -$210.85M derived: sum of 3 quarters · filed 2026-08-05 | -$278.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$102.55M 10-Q · filed 2026-05-08 | -$139.49M derived: sum of 2 quarters · filed 2026-05-08 | -$207.34M derived: sum of 3 quarters · filed 2026-05-08 | -$273.43M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$36.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$104.79M derived: sum of 2 quarters · filed 2026-03-03 | -$170.88M derived: sum of 3 quarters · filed 2026-03-03 | -$281.90M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$67.85M 10-Q · filed 2025-11-05 | -$133.94M derived: sum of 2 quarters · filed 2025-11-05 | -$244.96M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$66.09M 10-Q · filed 2025-08-12 | -$177.11M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$342.89M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |